АКТУАЛЬНЫЕ ВОПРОСЫ ДИАГНОСТИКИ И ЛЕЧЕНИЯ КАРЦИНОИДНОЙ БОЛЕЗНИ СЕРДЦА (КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕ)

РЕЗЮМЕ. Представлены данные, свидетельствующие о прогрессировании карциноидной болезни сердца, послужившие поводом для повторной госпитализации больной после эндокардинтимэктомии и множественного протезирования клапанов. Данные подтверждают, что в случаях сочетанного поражения клапанов правых отделов сердца следует исходить из высокой вероятности их карциноидного поражения. В этой связи, наряду с эхокардиографией особую ценность приобретает мультиспиральная компьютерная томография, позволяющая подтвердить диагноз, выявить метастазы в различных органах и определить локализацию первичного очага. Операция на открытом сердце может быть эффективной только в сочетании с хирургическим лечением первичной опухоли и использованием аналогов соматостатина.

1. MacGee W. Metastatic and invasive tumours involving the heart in a geriatric population: a necropsy study // Virchows Arch. A Pathol. Anat. Histopathol. – 1991. – Vol. 419, N. 3. – P. 183–189.

2. Бокерия Л.А., Малашенков А.И., Кавсадзе В.Э., Серов Р.А. Кардиоонкология. – М.: Изд-во НЦССХ им. А.Н.Бакулева РАМН, 2003. – 254 с. Bokeriya L.A., Malashenkov A.I., Kavsadze V.E., Serov R.A. Kardioonkologiya [Cardio-oncology]. Moscow: NTsSSKh im. A.N. Bakuleva RAMN Publ., 2003. 254 p. (In Russian).

3. Reynen K., Köckeritz U., Strasser R.H. Metastases to the heart // Ann. Oncol. – 2004. – Vol. 15, N. 3. – P. 375–381.

4. Grebenc M.L., Rosado de Christenson M.L., Burke A.P., et al. Primary cardiac and pericardial neoplasms: radiologic-pathologic correlation // Radiographics. – 2000. – Vol. 20, N. 4. – P. 1073–1103.

5. Sarjeant J.M., Butany J., Cusimano R.J. Cancer of the heart: epidemiology and management of primary tumors and metastases // Am. J. Cardiovasc. Drugs. – 2003. – Vol. 3, N. 6. – P. 407–421.

6. Butany J., Leong S.W., Carmichael K., Komeda M. A 30-year analysis of cardiac neoplasms at autopsy // Can. J. Cardiol. – 2005. – Vol. 21, N. 8. – P. 675–680.

7. Lam K.Y., Dickens P., Chan A.C. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies // Arch. Pathol. Lab. Med. – 1993. – Vol. 117, N. 10. – P. 1027–1031.

8. Yusuf S.W., Bathina J.D., Qureshi S., et al. Cardiac tumors in a tertiary care cancer hospital: clinical features, echocardiographic findings, treatment and outcomes // Heart Int. – 2012. – Vol. 7 , N. 1 . – e4.

9. Шхвацабая Л.В. Диагностика вторичного опухолевого поражения сердца // Клин. мед. – 1983. – № 11. – C. 61–65. Shkhvatsabaya L.V. Diagnostika vtorichnogo opukholevogo porazheni￾ya serdtsa [Diagnosis of secondary tumor lesions of the heart. Kliniches￾kaya meditsina. 1983; 11: 61–65. (In Russian).

10. Amano J., Nakayama J., Yoshimura Y., Ikeda U. Clinical classification of cardiovascular tumors and tumor-like lisions, and its incidences // Gen. Thorac. Cardiovasc. Surg. – 2013. – Vol. 61, N. 8. – P. 435–447.

11. Кнышов Г.В., Витовский Р.М., Захарова В.П. Опухоли сердца. Проблемы диагностики и хирургического лечения. – Киев: Книга плюс, 2005. – 254 с. Knyshov G.V., Vitovskiy R.M., Zakharova V.P. Opukholi serdtsa. Problemy diagnostiki i khirurgicheskogo lecheniya [Problems of diagnosis and surgical treatment]. Kiev: Kniga plyus publ., 2005; 254 p. (In Russian).

12. Pandya U.H., Pellikka P.A., Enriquez-Sarano M., et al. Metastatic carcinoid tumor to the heart: echocardiographic-pathologic study of 11 patients // J. Am. Coll. Cardiol. – 2002. – Vol. 40, N. 7. – P. 1328–1332.

13. Pellikka P.A., Tajik A.J., Khandheria B.K., et al. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation // 1993. – Vol. 87, N. 4. – P. 1188–1196.

14. Головин Д.И. Атлас опухолей человека (гистологическое строение). – Л.: Медицина, 1975. – 320 с. Golovin D.I. Atlas opukholey cheloveka (gistologicheskoe stroenie) [Atlas of human tumors (histology)]. Leningrad: Meditsina publ.,1975. 320 p. (In Russian).

15. Öberg K.E. Gastrointestinal neuroendocrine tumors // Ann Oncol. – 2010. – Vol. 21, Suppl 7. – vii 72–80.

16. Janson E.T., Holmberg L., Stridsberg M., et al. Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center // Ann. Oncol. – 1997. – Vol. 8, N. 7. – P. 685–690.

17. Максимова Т.М., Белов В.Б. Заболеваемость злокачественными новообразованиями и смертность от них в России и некоторых зарубежных странах // Проблемы социальной гигиены, здравоохранения и истории медицины. – 2012. – № 1. – С. 9–12. Maksimova T.M., Belov V.B. Zabolevaemost’ zlokachestvennymi novoo￾brazovaniyami i smertnost’ ot nikh v Rossii i nekotorykh zarubezhnykh stranakh [The incidence of malignant neoplasms and mortality in Russia and some foreign countries]. Problemy sotsial’noy gigieny, zdra￾vookhraneniya i istorii meditsiny. 2012; 1: 9–12. (In Russian).

18. Fox D., Khattar R. Carcinoid heart disease: presentation, diagnosis, and management // Heart. – 2004. – Vol. 90, N. 10. – P. 1224–1228.

19. Ross E.M., Roberts W.C. The carcinoid syndrome: comparison of 21 necropsy subjects with carcinoid heart disease to 15 necropsy subjects without carcinoid heart disease // Am. J. Med. – 1985. – Vol. 79, N. 3. – P. 339.

20. Bhattacharyya S., Davar J., Dreyfus G., Caplin M. Carcinoid heart disease // Circulation. – 2007. – Vol. 116, N. 24. – P. 2860–2865.

21. Bernheim A., Connolly H., Hobday T., et al. Carcinoid heart disease // Prog. Cardiovas. Dis. – 2007. – Vol. 49, N. 6. – P. 439–451.

22. Moller J.E., Connolly H.M., Rubin J., et al. Factors associated with progression of carcinoid heart disease // N. Engl. J. Med. – 2003. – Vol. 348, N. 11. – P. 1005–1015.

23. Zuetenhost J., Bonfrer J., Korse C., et al. Carcinoid heart disease. The role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-betta and fibroblast growth factor // Cancer. – 2003. – Vol. 97, N. 7. – P. 1609–1615.

24. Lundin L., Norheim I., Landelius J., et al. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities // Circulation. – 1988. – Vol. 77, N. 2. – P. 264– 269.

25. Moller J., Pellikka P., Bernheim A., et al. Prognosis of carcinoid heart disease analysis of 200 cases over two decades // Circulation. – 2005. – Vol. 112, N. 2. – P. 3320–3327.

26. Ragland M.M., Tak T. The Role of Echocardiography in Diagnosing Space-Occupying Lesions of the Heart // Clin. Med. Res. – 2006. – Vol. 4, N. 1. – P. 22–32.

27. Bastarrika G., Cao M.G., Cano D., et al. Magnetic resonance imaging diagnosis of carcinoid heart disease // J. Comput. Assist. Tomogr. – 2005. – Vol. 29, N. 6. – P. 756–759.

28. Prakash P., Kalra M.K., Stone J.R., et al. Imaging findings of pericardial metastasis on chest computed tomography // J. Comput. Assist. Tomogr. – 2010. – Vol. 34, N. 4. – P. 554–558.

29. Connolly H.M., Schaff H.V., Mullany C.J., et al. Surgical management of left-sided carcinoid heart disease // Circulation. – 2001. – Vol. 104, N. 12. – Suppl. 1. – P. 136–140.

30. Connolly H.M., Schaff H.V., Mullany C.J., et al. Carcinoid heart disease: impact of pulmonary valve replacement in right ventricular function and remodeling // Circulation. – 2002. – Vol. 106, N. 12. – Suppl. 1. – P. 151–156.

31. Mokhles P., Herwerden P., Herder W., et al. Carcinoid heart disease: outcomes after surgical valve replacement // Eur. J. Cardio-Thoracic Surgery. – 2012. – Vol. 41, N. 6. – P. 1278–1283.

32. Narine K., Dohmen P., Daenen W. Tricuspid and pulmonary valve involvement in carcinoid disease // Tex. Heart Inst. J. – 2000. – Vol. 27, N. 4. – P. 405–407.

33. Bhattacharyya S. eComment. Cardiovascular surgery in carcinoid heart disease // Interact. Cardiovasc. Thorac. Surg. – 2012. – Vol. 15, N. 3. – P. 471.

34. Thorburn C.W., Morgan J.J., Shanahan M.X., Chang V.P. Long-term results of tricuspid valve replacement and the problem of prosthetic valve thrombosis // Am. J. Cardiol. – 1983. – Vol. 51, N. 7. – P. 1128– 1132.

35. Komoda S., Komoda T., Pavel M.E., et al. Cardiac surgery for carcinoid heart disease in 12 cases // Gen. Thor. Cardiovas. Surg. – 2011. – Vol. 59, N. 12. – P. 780–785.

36. Castillo J.G., Filsoufi F., Rahmanian P.B., et al. Early and Late Results of Valvular Surgery for Carcinoid Heart Diseas // J. Amer. Coll Card. – 2008. – Vol. 51, N. 15. – P. 1507–1509.

37. Mabvuure N., Cumberwortha A., Hindochab S. In patients with carcinoid syndrome undergoing valve replacement: will a biological valve have acceptable durability? // Interact. Cardiovasc. Thorac. Surg. – 2012. – Vol. 15, N. 3. – P. 467–472.

38. Hajj-Chahine J., Jayle C., Houmaida H., Corbi P. eComment. Valve replacement in carcinoid heart disease // Interact. Cardiovasc. Thorac. Surg. – 2012. – Vol. 15, N. 3. – P. 471–472.

39. Mokhles P., van Herwerden L.A., de Jong P.L., et al. Carcinoid heart disease: outcomes after surgical valve replacement // Eur. J. Cardiothorac. Surg. – 2012. – Vol. 41, N. 6. – P. 1278–1283.

40. Vaughan D.J., Brunner M.D. Anesthesia for patients with carcinoid syndrome // Int. Anesthesiol. Clin. – 1997. – Vol. 35, N. 4. – P. 129–142.

41. Connolly H.M., Pellikka P.A. Carcinoid heart disease // Curr. Cardiol. Rep. – 2006. – Vol. 8, N. 2. – P. 96–101.

42. Corleto V.D., Angeletti S., Schillaci O., Marignani M. Long-term octreotide treatment of metastatic carcinoid tumor // Ann. Oncol. – 2000. – Vol. 11, N. 4. – P. 491–493.